Article
Assessment of primary, oxidative and excision repaired DNA damage in hospital personnel handling antineoplastic drugs.
Mutagenesis - 1 May 2011
Villarini Milena, Dominici Luca, Piccinini Renza, Fatigoni Cristina, Ambrogi Maura, Curti Gianluca, Morucci Piero, Muzi Giacomo, Monarca Silvano, Moretti Massimo
Abstract excerpt
The International Agency for Research on Cancer has classified several antineoplastic drugs in Group 1 (human carcinogens), among which chlorambucil, cyclophosphamide (CP) and tamoxifen, Group 2A (probable human carcinogens), among which cisplatin, etoposide, N-ethyl- and N-methyl-N-nitrosourea, and Group 2B (possible human carcinogens), among which bleomycins, merphalan and mitomycin C. The widespread use of...
Topics
- Antineoplastic Agents
- Cancer Care Facilities
- Comet Assay
- Cytarabine
- DNA Damage
- Fluorouracil
- Genotype
- Glutathione S-Transferase pi
- Glutathione Transferase
- Humans
